Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 128, 2022 - Issue 1
91
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Group-specific component exon 11 haplotypes (D432E and T436K) and risk of albuminuria in type 2 diabetes mellitus patients

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 111-120 | Received 17 May 2019, Accepted 03 Sep 2019, Published online: 18 Sep 2019

References

  • Agnello, L., et al., 2017. VDBP, CYP27B1, and 25-hydroxyvitamin D gene polymorphism analyses in a group of sicilian multiple sclerosis patients. Biochemical genetics, 55(2), 183–192.
  • Alenizi, D., 2014. Consanguinity pattern and heritability of Vitiligo in Arar, Saudi Arabia. The journal of family and community medicine, 21(1), 13–16.
  • Baier, L.J., et al., 1998. Variations in the vitamin D-binding protein (Gc locus) are associated with oral glucose tolerance in nondiabetic Pima Indians. Journal of clinical endocrinology and metabolism, 83(8), 2993–2996.
  • Blanton, D., et al., 2011. Reduced serum vitamin D-binding protein levels are associated with type 1 diabetes. Diabetes, 60(10), 2566–2570.
  • Braun, A., Bichlmaier, R., and Cleve, H., 1992. Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types. Human genetics, 89(4), 401–406.
  • Caldwell, J.D. and Jirikowski, G.F., 2014. Sex hormone binding globulin and corticosteroid binding globulin as major effectors of steroid action. Steroids, 81, 13–16.
  • Campion, C.G., Sanchez-Ferras, O., and Batchu, S.N., 2017. Potential role of serum and urinary biomarkers in diagnosis and prognosis of diabetic nephropathy. Canadian journal of kidney health and disease, 4, 1–8.
  • Chen, H., et al., 2015. Vitamin D binding protein gene polymorphisms and chronic obstructive pulmonary disease: a meta-analysis. Journal of thoracic disease, 7(8), 1423–1440.
  • Cho, E.H., et al., 2007. The discovery of biomarkers for type 2 diabetic nephropathy by serum proteome analysis. Proteomics – clinical applications, 1(4), 352–3561.
  • Christiansen, M., et al., 2007. Protein chemical characterization of Gc globulin (vitamin D-binding protein) isoforms; Gc-1f, Gc-1s and Gc-2. Biochimica et biophysica acta (BBA) – proteins and proteomics, 1774(4), 481–492.
  • Conserva, F., Gesualdo, L., and Papale, M., 2016. A systems biology overview on human diabetic nephropathy: from genetic susceptibility to post-transcriptional and post-translational modifications. Journal of diabetes research, 2016, 7934504.
  • Fawzy, M.S. and Abu AlSel, B.T., 2018. Assessment of vitamin D binding protein and early prediction of nephropathy in type II Saudi diabetic patients. Journal of diabetes research, 2018, 8517929.
  • Fu, L., et al., 2009. Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25 (OH) D] to vitamin D supplementation. Clinical biochemistry, 42(10–11), 1174–1177.
  • Ha, S.-K., 2014. ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implications of genetic information. Journal of diabetes research, 2014, 846068.
  • Hirai, M, et al., 2000. Variations in vitamin D-binding protein (group-specific component protein) are associated with fasting plasma insulin levels in Japanese with normal glucose tolerance. Journal of clinical endocrinology and metabolism, 85(5), 1951–1953. 
  • Hirai, M., et al., 1998. Group specific component protein genotype is associated with NIDDM in Japan. Diabetologia, 41(6), 742–743.
  • Hiroki, T., et al., 2006. The human vitamin D-binding protein gene contains locus control determinants sufficient for autonomous activation in hepatic chromatin. Nucleic acids research, 34(8), 2154–2165.
  • International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Brussels: International Diabetes Federation 2017. Available from: http://www.diabetesatlas.org [Accessed 1 April 2018].
  • Iyengar, S.K., et al., 2015. Family investigation of nephropathy and diabetes (FIND). Genome-wide association and trans-ethnic meta-analysis for advanced diabetic kidney disease: family investigation of nephropathy and diabetes (FIND). PLoS genetics, 11(8), e1005352.
  • Klupa, T., et al., 1999. Amino acid variants of the vitamin D-binding protein and risk of diabetes in white Americans of European origin. European journal of endocrinology, 141(5), 490–493.
  • Lemos, M.C., et al., 2008. Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population. Human immunology, 69(2), 134–138.
  • Li, H., et al., 2013. A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans. Diabetes, 62(1), 291–298.
  • Łukaszewicz-Zajac, M., et al., 2008. [The significance of Gc-globulin in clinical practice]. Postepy Higieny i Medycyny Doswiadczalnej (Online)), 62, 625–631.
  • Mahmoud, M., et al., 2011. Lack of association of vitamin D binding protein polymorphisms in Egyptian children with type 1 diabetes. Turkish journal of endocrinology and metabolism, 15(4), 111–115.
  • Malecki, M.T., et al., 2002. Vitamin D binding protein gene and genetic susceptibility to type 2 diabetes mellitus in a Polish population. Diabetes research and clinical practice, 57(2), 99–104.
  • Malik, S., et al., 2013. Common variants of the vitamin D binding protein gene and adverse health outcomes. Critical reviews in clinical laboratory sciences, 50(1), 1–22.
  • McCune, B. and Mefford, M. J., 2006. PC-ORD: multivariate analysis of ecological data, version 5. Gleneden Beach, OR: MjM Software Design, USA.
  • Powe, C.E., et al., 2013. Vitamin D-binding protein and vitamin D status of Black Americans and White Americans. New England journal of medicine, 369(21), 1991–2000.
  • Signorello, L.B., et al., 2011. Common variation in vitamin D pathway genes predicts circulating 25-hydroxyvitamin D Levels among African Americans. PLoS one, 6(12), e28623.
  • Speeckaert, M., et al., 2006. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clinica chimica acta, 372(1–2), 33–42.
  • Stakisaitis, D., et al., 2016. Investigation of vitamin D-binding protein polymorphism impact on coronary artery disease and relationship with longevity: own data and a review. International journal of endocrinology, 2016, 8347379.
  • Talmud, P.J., et al., 2010. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ, 340, b4838.
  • Toraih, E., Hussein, M.H., and Badran, D.I., 2014. Beta2-adrenergic receptor gene polymorphisms in Egyptian patients with acute myocardial infarction. Advances in molecular biology, 2014, 471635.
  • Wang, G., et al., 2014. Association of the vitamin D binding protein polymorphisms with the risk of type 2 diabetes mellitus: a meta-analysis. BMJ open, 4(11), e005617.
  • White, P. and Cooke, N., 2000. The multifunctional properties and characteristics of vitamin D-binding protein. Trends in endocrinology & metabolism, 11(8), 320–327.
  • Ye, W.Z., et al., 2001. Variations in the vitamin D-binding protein (Gc locus) and risk of type 2 diabetes mellitus in French Caucasians. Metabolism, 50(3), 366–369.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.